IDH1-mutant SHH MBs were determined to be CIMP+ (Extended Data Fig. 6f, g), confirming that these mutations lead to epigenetic consequences reminiscent of those reported in other IDH1/2-mutant cancers. The gene discussed is IDH1; the disease is cancer.